Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
about
The role of vaccination in preventing pneumococcal disease in adultsThe anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventionsBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.Lifestyle risk factors for invasive pneumococcal disease: a systematic review.Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.Vaccine herd effect.IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children.Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China.Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infectionsIn vitro growth of pneumococcal isolates representing 23 different serotypes.Evolution of the capsular gene locus of Streptococcus pneumoniae serogroup 6.Phenotypic and genotypic characteristic of invasive pneumococcal isolates from both children and adult patients from a multicenter surveillance in China 2005-2011.The bacterial interactions in the nasopharynx of children receiving adenoidectomy.Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.Invasive pneumococcal diseases in children and adolescents--a single centre experienceRole of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptorsEnhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production.Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.Neonatal Streptococcus pneumoniae infection may aggravate adulthood allergic airways disease in association with IL-17A.Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.Ni2+-Dependent and PsaR-Mediated Regulation of the Virulence Genes pcpA, psaBCA, and prtA in Streptococcus pneumoniae.Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens.Factors Associated with Streptococcal Bacteremia in Diarrheal Children under Five Years of Age and Their Outcome in an Urban Hospital in BangladeshGeneration and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae.A comparative public health and budget impact analysis of pneumococcal vaccines: The French caseChitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.Study of Invasive Pneumococcal Infection in Adults with Reference to Penicillin Resistance.Theory and strategy for Pneumococcal vaccines in the elderly.Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based studyImproving pneumococcal vaccination rates of medical inpatients in urban Nepal using quality improvement measures.Streptococcus pneumoniae bacteremia: clinical and microbiological epidemiology in a health area of Southern Spain.Pneumococci: immunology of the innate host response.Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.Acute bacterial meningitis in infants and children: epidemiology and management.Opportunistic infections due to inflammatory bowel disease therapy.Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
P2860
Q28396749-1EF3BA5F-D875-4843-93B4-C9CC1E6E9036Q28732491-ED5C997D-E56A-473C-830C-200E1DE069ECQ30251593-1076A1F3-4BFD-4A52-A905-4CCA20C47A19Q30830558-ABC694B0-D271-4A98-85C4-557ABAF31ECEQ33795662-B04C6C16-4E93-4B07-B39C-956E6905B06FQ33990842-51403E93-96BB-44F5-8ED8-AB9FB9BFCE90Q34186752-FFBC21A4-16B4-4A23-8679-F4A788514B45Q34262840-4275E14D-DC2F-498F-B892-30EE1C024339Q34398550-2A2691C5-B98C-45BD-A1C1-C2CDF3AFB272Q34434577-A2BE94AE-9FB5-4817-8F53-FF9F0EEACF25Q34516757-C95A1682-C41B-4F7D-ACD4-269BB0CFC5C8Q34568182-019803B3-A2C6-4920-83F1-94814669ABEFQ34736040-7A2B66AA-39DB-43CB-B0B2-B28B93079425Q34746789-3735BBC5-C98E-4CA4-946D-F56B0265C6A6Q35070203-4DAF621C-8DE8-424E-9CC1-AF36C980AB74Q35079773-3FAC3BBE-2493-4B6D-8C27-53C62D39CA5AQ35092077-37FA9AB3-B895-424A-966A-249DBB9F51D3Q35119564-408687C5-EFA2-45A2-BB2F-9BB332C5E640Q35162960-139F41A0-1EA6-41D4-9007-5A0738F479ADQ35178687-875FA46A-BDB1-419D-9D5B-B0D1E982345AQ35181390-C15A2DAA-DAA9-4590-82A8-3F8F11550773Q35224875-F1552BEE-95F6-4827-AD3C-DA17814ED477Q35609664-83BB1696-3FB2-4915-A242-CB29CBFDA070Q35816192-EBC90566-1B20-4D9A-871D-592FC59529ADQ35839946-39E64A15-CE1E-4CD9-9E0F-5E83B7C4AB29Q35963490-818FC35E-7B88-43A7-A1C4-E2077615BC45Q36005109-79088FE5-FD8C-4124-9ECF-AE49C06F397FQ36015321-1FF6E1A6-162B-418C-9D1A-B9264047E483Q36255763-D1192EC6-F1E3-4B01-97FC-D6DE55A1E233Q36731284-C3CFF596-F6DA-46F6-816B-387392CE2CDDQ37241030-26DEDA9C-AB67-4649-BC3A-3B046D86FDB1Q37309215-7EAF11EF-5387-46E8-9B52-BBC7839179B1Q37432896-D24823AB-EEBC-4FDE-81AA-5327CC1577CFQ37453743-C0040944-A0FD-4163-ADFD-AB61BC6DC043Q37482000-555E3E45-AE17-475F-BE34-8B0F3ECB169FQ37774429-A20CE99B-6ACA-4255-AC49-BBA130F6DEE8Q37910264-16601949-F30B-408B-9D86-BCB09E728FA1Q37945754-29AC5476-AA46-4855-B893-260737EA9B49Q38139812-6F4624BE-6C8B-4124-8D6A-D3FBC85CA961Q38447464-59406A7D-7FB8-417E-A18B-DD100DAC7954
P2860
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@en
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@nl
type
label
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@en
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@nl
prefLabel
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@en
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@nl
P356
P1476
Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.
@en
P2093
Joseph P Lynch
P304
P356
10.1055/S-0029-1202938
P577
2009-03-18T00:00:00Z